1.山东中医药大学中医学院,山东省济南市历下区经十路16369号,250014
2.山东中医药大学第一临床医学院
3.山东中医药大学附属医院
13864049036@163.com
收稿:2023-08-15,
修回:2023-11-08,
纸质出版:2024-03-17
移动端阅览
于明玥,杨婕,陈朴等.刘瑞芬运用三期祛瘀法治疗子宫内膜增生症经验[J].中医杂志,2024,65(06):566-571.
YU Mingyue,YANG Jie,CHEN Pu,et al.LIU Ruifen's Experience in Treating Endometrial Hyperplasia with Three-staged Stasis Dispelling Method[J].Journal of Traditional Chinese Medicine,2024,65(06):566-571.
于明玥,杨婕,陈朴等.刘瑞芬运用三期祛瘀法治疗子宫内膜增生症经验[J].中医杂志,2024,65(06):566-571. DOI: 10.13288/j.11-2166/r.2024.06.004.
YU Mingyue,YANG Jie,CHEN Pu,et al.LIU Ruifen's Experience in Treating Endometrial Hyperplasia with Three-staged Stasis Dispelling Method[J].Journal of Traditional Chinese Medicine,2024,65(06):566-571. DOI: 10.13288/j.11-2166/r.2024.06.004.
总结刘瑞芬教授治疗子宫内膜增生症的临证经验。认为伏瘀内阻胞宫胞络为子宫内膜增生症的核心病机,结合疾病临床表现将月经周期分为经行期、经漏期、经净期3个阶段,提出三期祛瘀法。经行期伏瘀积久化癥,治宜行气活血、化瘀消癥,自拟宫清方;经漏期气阴两虚兼瘀热互结,治宜益气清热、祛瘀止血,自拟通用止血方;经净期易因痰、郁加重伏瘀,治宜化痰散结、行气祛瘀,自拟止痛调血方。同时重视辨证与辨病相结合,中西医协同诊疗。
This paper summarized professor LIU Ruifen's clinical experience in treating endometrial hyperplasia. It is believed that the core pathogenesis of endometrial hyperplasia is internal obstruction of uterus and intrauterine collaterals by latent stasis. Based on the clinical manifestations, the menstrual cycle is divided into three stages, that is menstrual period, menstrual leakage period, and clear menstrual period, and the method of “three-staged stasis dispelling” is proposed. During the menstrual period, it is appropriate to move
qi
and invigorate blood, dissolve stasis and disperse concretions, with self-made
Gongqing Formula
(宫清方). For menstrual leakage period, it is suggested to boost
qi
and clear heat, dispel stasis and stanch bleeding, with self-made
Tongyong Zhixue Formula
(通用止血方). In terms of clear menstrual period, the method of dissolving phlegm and dissipating masses, moving
qi
and dispelling stasis is advised, and self-made
Zhitong Tiaoxue Formula
(止痛调血方) can be used. Simultaneously, attention should be paid to the combination of syndrome differentiation and disease differentiation, as well as collaborative diagnosis and treatment with traditional Chinese and Western medicine.
全国卫生产业企业管理协会妇幼健康产业分会生殖内分泌学组 . 中国子宫内膜增生诊疗共识 [J]. 生殖医学杂志 , 2017 , 26 ( 10 ): 957 - 960 .
谢庆生 , 刘从容 , 谢晓飞 , 等 . 《FIGO 2018妇癌报告》:病理及分子病理学指南解读 [J]. 中国实用妇科与产科杂志 , 2019 , 35 ( 4 ): 424 - 430 .
陈佳文 , 胡丽娜 . 子宫内膜增生诊断和药物治疗研究进展 [J]. 中国药业 , 2022 , 31 ( 5 ): 128 - 132 .
韩倩 , 刘永 , 赵瑞华 . 子宫内膜增生症的中西医治疗进展 [J]. 现代中西医结合杂志 , 2019 , 28 ( 8 ): 908 - 912 .
吴晓华 , 徐丽霞 . 加减苁蓉菟丝子丸随证治疗子宫内膜增生症的效果观察 [J]. 实用妇科内分泌电子杂志 , 2022 , 9 ( 6 ): 88 - 91 .
惠月红 , 程文俊 , 赵绍杰 , 等 . 育肾培元方辨证治疗子宫内膜增生症肾虚血瘀证的临床疗效 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 24 ): 189 - 194 .
夏阳 , 张吉金 , 哈孝廉 , 等 . 益肾软坚法对子宫内膜囊腺型增生性功血患者子宫内膜雌、孕激素受体及超微结构的影响 [J]. 中医杂志 , 2000 , 41 ( 8 ): 476 - 479 .
陈小燕 , 周征 , 王素云 . 中医治疗对单纯型子宫内膜增生症的患者负性情绪的影响及护理干预的效果 [J]. 中国医药指南 , 2013 , 11 ( 28 ): 224 - 225 .
张雪珥 , 庞尧斌 , 王栩芮 , 等 . 艾儒棣运用“伏瘀”理论治疗慢性荨麻疹复发经验 [J]. 中医杂志 , 2022 , 63 ( 12 ): 1113 - 1117 .
田硕 , 苗明三 . 益母草现代研究分析 [J]. 中医学报 , 2014 , 29 ( 1 ): 64 - 67 .
谷灿灿 , 陈静 , 陈稳根 , 等 . 蒲黄妇科方药考略 [J]. 中医文献杂志 , 2022 , 40 ( 6 ): 90 - 93 .
赵旭功 , 吴经纬 , 张西荣 , 等 . 马齿苋的药理研究及临床应用 [J]. 山东医药工业 , 2002 , 21 ( 4 ): 34 - 36 .
陈文鹏 , 卢健棋 , 庞延 , 等 . 仙鹤草化学成分、药理作用及临床应用研究进展 [J]. 辽宁中医药大学学报 , 2022 , 24 ( 6 ): 118 - 122 .
贺玉婷 , 樊启猛 , 石继连 , 等 . 中药炭药的临床应用及止血作用机制研究进展 [J]. 中国实验方剂学杂志 , 2021 , 27 ( 7 ): 201 - 208 .
0
浏览量
1
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号